440 related articles for article (PubMed ID: 27538267)
1. Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.
Jalil O; Afaq A; Ganeshan B; Patel UB; Boone D; Endozo R; Groves A; Sizer B; Arulampalam T
Colorectal Dis; 2017 Apr; 19(4):349-362. PubMed ID: 27538267
[TBL] [Abstract][Full Text] [Related]
2. Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance.
De Cecco CN; Ganeshan B; Ciolina M; Rengo M; Meinel FG; Musio D; De Felice F; Raffetto N; Tombolini V; Laghi A
Invest Radiol; 2015 Apr; 50(4):239-45. PubMed ID: 25501017
[TBL] [Abstract][Full Text] [Related]
3. Low- Versus High-Risk Rectal Cancer Based on MRI Features: Outcomes in Patients Treated Without Neoadjuvant Chemoradiotherapy.
Jia XX; Wang Y; Cheng J; Yao X; Yin MJ; Zhou J; Ye YJ
AJR Am J Roentgenol; 2018 Aug; 211(2):327-334. PubMed ID: 29927331
[TBL] [Abstract][Full Text] [Related]
4. CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
Chee CG; Kim YH; Lee KH; Lee YJ; Park JH; Lee HS; Ahn S; Kim B
PLoS One; 2017; 12(8):e0182883. PubMed ID: 28797063
[TBL] [Abstract][Full Text] [Related]
5. MRI features and texture analysis for the early prediction of therapeutic response to neoadjuvant chemoradiotherapy and tumor recurrence of locally advanced rectal cancer.
Park H; Kim KA; Jung JH; Rhie J; Choi SY
Eur Radiol; 2020 Aug; 30(8):4201-4211. PubMed ID: 32270317
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging performed before and after preoperative chemoradiotherapy in rectal cancer: predictive factors of recurrence and prognostic significance of MR-detected extramural venous invasion.
Prampolini F; Taschini S; Pecchi A; Sani F; Spallanzani A; Gelsomino F; Kaleci S; Torricelli P
Abdom Radiol (NY); 2020 Oct; 45(10):2941-2949. PubMed ID: 30483843
[TBL] [Abstract][Full Text] [Related]
7. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
9. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival.
Zhang XY; Wang S; Li XT; Wang YP; Shi YJ; Wang L; Wu AW; Sun YS
Radiology; 2018 Dec; 289(3):677-685. PubMed ID: 30152742
[TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Aker M; Ganeshan B; Afaq A; Wan S; Groves AM; Arulampalam T
Dis Colon Rectum; 2019 Feb; 62(2):163-170. PubMed ID: 30451764
[TBL] [Abstract][Full Text] [Related]
11. Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI.
Bellini D; Carbone I; Rengo M; Vicini S; Panvini N; Caruso D; Iannicelli E; Tombolini V; Laghi A
Tomography; 2022 Aug; 8(4):2059-2072. PubMed ID: 36006071
[TBL] [Abstract][Full Text] [Related]
12. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation.
Chand M; Rasheed S; Heald R; Swift I; West N; Rao S; Tekkis P; Brown G
Colorectal Dis; 2017 Jun; 19(6):537-543. PubMed ID: 27673438
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.
Lee ES; Kim MJ; Park SC; Hur BY; Hyun JH; Chang HJ; Baek JY; Kim SY; Kim DY; Oh JH
Eur Radiol; 2018 Feb; 28(2):496-505. PubMed ID: 28786006
[TBL] [Abstract][Full Text] [Related]
15. MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
Cho MS; Park YY; Yoon J; Yang SY; Baik SH; Lee KY; Kim IY; Kim NK
J Surg Oncol; 2018 Jun; 117(8):1823-1832. PubMed ID: 29790177
[TBL] [Abstract][Full Text] [Related]
16. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
17. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
[TBL] [Abstract][Full Text] [Related]
18. MRI morphologic and clinicopathologic characteristics for predicting outcomes in patients with locally advanced rectal cancer.
Meng Y; Wan L; Ye F; Zhang C; Zou S; Zhao X; Xu K; Zhang H; Zhou C
Abdom Radiol (NY); 2019 Nov; 44(11):3652-3663. PubMed ID: 30456561
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
[TBL] [Abstract][Full Text] [Related]
20. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial.
Patel UB; Brown G; Machado I; Santos-Cores J; Pericay C; Ballesteros E; Salud A; Isabel-Gil M; Montagut C; Maurel J; Ramón-Ayuso J; Martin N; Estevan R; Fernandez-Martos C
Ann Oncol; 2017 Feb; 28(2):344-353. PubMed ID: 28426108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
